Fortify is excited to announce that it is a recipient of a charitable contribution from Akebia Therapeutics, a U.S.-based biopharmaceutical company.
This grant helps sustain our work towards reducing iron deficiency anemia (IDA), said Nancy K. Martin, CEO & Founder of Fortify.